Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
Open Access
- 21 September 2023
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 23 (1) , 1-10
Abstract
At present, a large number of studies have found that long non-coding RNAs (lncRNAs) can be used as biomarkers for diagnosis and monitoring prognosis of hepatocellular carcinoma (HCC). The expression of lncRNA cancer susceptibility candidate 7 (CASC7) in HCC has rarely been studied. The purpose of this study was to explore the expression of CASC7 and its correlation with clinical features, and to further analyze its diagnostic value in HCC. Serum samples were collected from 80 patients with HCC, 80 patients with chronic hepatitis B (CHB), and 80 healthy people. The expression level of serum CASC7 was detected by droplet digital PCR. Appropriate parametric and nonparametric tests were used for data analysis. The results showed that the expression of CASC7 in serum of patients with HCC was significantly higher than that of patients with CHB (median: 8.8 versus 2.2 copies/µl, p < 0.001) and healthy controls (median: 8.8 versus 3.8 copies/µl, p < 0.001). High expression of serum CASC7 was significantly correlated with tumor number (p = 0.005), intrahepatic metastasis (IM) (p < 0.001), tumor size (p = 0.007) and tumor-node-metastasis (TNM) stage (p = 0.008). The area under the curve (AUC) of CASC7 to distinguish HCC patients from CHB patients and healthy controls was 0.808 (95% CI: 0.742–0.874) at the cut-off value of 7.24 copies/µl with 63.8% sensitivity and 95.2% specificity. This study suggested that CASC7 was significantly up-regulated in serum of patients with HCC and closely related to tumor number, IM, tumor size and TNM stage, which may serve as a promising diagnostic biomarker.Keywords
Funding Information
- Chongqing Clinical Key Specialty Construction Project
- Science and Technology Commission of the CMC National Defense Innovation Special Zone (18-163-15-ZT-001-007-22)
- Excellent talents fund of Daping Hospital and the major project of Army Medical University (2018 XLC 2027)
This publication has 40 references indexed in Scilit:
- Long noncoding RNA in liver diseasesHepatology, 2014
- Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular CarcinomaBioMed Research International, 2013
- Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentinHepatology, 2012
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA: A Cancer Journal for Clinicians, 2012
- Genome Regulation by Long Noncoding RNAsAnnual Review of Biochemistry, 2012
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humansHepatology, 2011
- Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNAGastroenterology, 2007
- Digital PCRProceedings of the National Academy of Sciences, 1999
- CEA, AFP and Other Potential Tumor MarkersCA: A Cancer Journal for Clinicians, 1975